Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma
Santhoshkumar Sundaramoorthy(Ajou University), Nicolò Riggi(University Hospital of Lausanne)
Cited by 2
Related Papers
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
|Cancer Research|2005|360
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
|Nature Medicine|2021|127